Gemcitabine hydrochloride, an antimetabolite used for pancreatic adenocarcinoma in humans, requires phosphorylation in the intracellular environment by the enzyme deoxycytidine kinase, encoded by the DCK gene [71]. The gene discussed is DCK; the disease is pancreatic adenocarcinoma.